SOHM

What SOHM does

SOHM Inc. is a US-based public company (OTC Pink: SHMN) operating four business units: Nutraceuticals/OTC consumer health products, generic Pharmaceuticals, a Biotech Division built around the proprietary ABBIE gene-editing platform, and CDMO contract manufacturing services. The Nutraceuticals/OTC portfolio includes biotin and multivitamin gummies, turmeric/ginger gummies, Nail Renovar and Nail Renovar Plus antifungal solutions, the FOHM foam face wash, and iProlec nutritional supplements, distributed through Amazon US and UK, Walmart Global Seller, and a Shopify storefront. The Pharmaceutical unit produces generic Levetiracetam for epilepsy across 250mg-1000mg strengths, with exclusive distribution agreements including Stallion Laboratories in India. The Biotech Division is centered on ABBIE (A Binding Based Integrase Enzyme), a Cas9-guided retroviral integrase platform that enables programmable DNA insertion without double-strand breaks or viral vectors, with issued patents in China and pending applications in the US, EU, Japan, and South Korea; preclinical applications include CAR-T cell engineering and the recently announced SKOV3-GYS1 drug-discovery cell line. The CDMO segment offers formulation, testing, packaging, labeling, and global distribution under cGMP, FDA, and EPA licenses from a 5,500 sq ft San Diego facility and a Carlsbad GMP-compliant topical production facility launched in November 2023, with Vista manufacturing and a Tucson R&D presence at the University of Arizona Center for Innovation. Revenue mechanics combine direct-to-consumer retail sales, B2B private-label manufacturing, exclusive distributor agreements in emerging markets (Africa, Latin America, Southeast Asia), and a developing licensing pipeline for ABBIE; Q1 2023 reported revenue was $52,000 with 14% YoY growth.

Name

SOHM

Legal name

SOHM, Inc.

Website

https://sohm.com

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Short description

SOHM Inc. is a US public company (OTC Pink: SHMN) operating four units: OTC nutraceuticals, generic pharmaceuticals, CDMO services, and the proprietary ABBIE non-viral gene-editing platform, serving consumers via Amazon/Walmart/Shopify, emerging-market distributors, and biotech partners.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Nutraceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Generic pharmaceuticals
• Nutraceutical manufacturing
• Contract development manufacturing
• Gene editing technology
• Cosmeceutical products

Headquarters

HQ city

Buena Park

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Manufacturing and distribution of generic and branded generic pharmaceuticals including Levetiracetam for seizure control. Products exported globally with focus on emerging markets in Africa, Latin America, and Southeast Asia.
2. Nutraceutical and OTC Products: Private label and SOHM-branded nutraceuticals including gummies (biotin, multivitamin, turmeric/ginger), Nail Renovar, Nail Renovar Plus, FOHM face wash, and iProlec supplements sold through Amazon, Walmart, and direct-to-consumer Shopify store.
3. CDMO/Contract Manufacturing Services: Contract development and manufacturing organization services for topical drugs, skincare, and pharmaceutical products. Services include formulation development, testing, packaging, and global distribution support for private label customers.
4. Gene Editing Technology Licensing: ABBIE platform technology licensing opportunities for research, synthetic biology, and therapeutic applications including CAR-T therapy development and cell engineering.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

SOHM Inc. is a diversified biopharmaceutical and wellness company that develops, manufactures, and distributes generic pharmaceuticals, nutraceuticals, and cosmeceuticals across multiple business units. Its operations span an OTC nutraceutical division (gummy vitamins, hair/skin/nail products), a pharmaceuticals division (generic Levetiracetam tablets and capsules), a biotech division (ABBIE gene editing platform with patented CRISPR-related IP), and a CDMO services unit offering contract development, manufacturing, and private-label services from facilities in Carlsbad and San Diego.

Product overview

SOHM Inc. is a diversified biotechnology company operating across four core business units: Nutraceuticals/OTC, Pharmaceuticals, Biotech Division, and CDMO services. The product portfolio includes: Gummies (Biotin Multivitamin, Multivitamin Multimineral, Turmeric and Ginger), Nail Renovar and Nail Renovar Plus (antifungal treatments), FOHM (cosmeceutical face wash), iProlec (nutritional supplement), Levetiracetam (generic anti-epileptic pharmaceutical), the ABBIE gene editing platform (biotech), and comprehensive CDMO/manufacturing/distribution services. The company operates a 5,500 sq ft FDA-compliant manufacturing facility in San Diego and a GMP-compliant topical production facility in Carlsbad, California.

Differentiator

Problem solved

Functional benefit

Products and services

• Nail Renovar Nail Renovar is a cosmeceutical product for nail health and appearance, sold as part of SOHM's FOHM consumer product line. It is targeted at individual consumers seeking beauty and self-care solutions.
• Nail Renovar Plus Nail Renovar Plus is an upgraded cosmeceutical nail-care product, part of SOHM's FOHM consumer wellness line for nail strengthening and care.
• Biotin Multivitamin Gummies Biotin Multivitamin Gummies are an OTC nutraceutical supplement combining biotin with multivitamins, manufactured and sold by SOHM for consumer health and beauty support.
• Multivitamin Multimineral Gummies Multivitamin Multimineral Gummies are an OTC dietary supplement offering daily nutritional support, sold to individual consumers via SOHM's retail channels.
• Turmeric and Ginger Gummies Turmeric and Ginger Gummies are an OTC nutraceutical supplement combining turmeric and ginger extracts for joint and anti-inflammatory support, sold to consumers.
• Levetiracetam Generic Pharmaceutical Levetiracetam is a generic anti-epileptic pharmaceutical offered by SOHM in tablet and capsule form, manufactured under an FDA-compliant framework and distributed via partners in emerging markets for the treatment of seizures.
• ABBIE Gene Editing Platform The ABBIE Gene Editing Platform is SOHM's proprietary CRISPR-related gene editing technology offered to research institutions, therapeutic developers, and agricultural biotech partners for precise genome editing applications.
• CDMO Services SOHM's CDMO Services provide end-to-end contract development and manufacturing for nutraceutical, cosmeceutical, and pharmaceutical clients, including private-label production, formulation, and packaging from SOHM's FDA-compliant facilities.

Quantifiable outcome

• ABBIE-engineered SKOV3-GYS1 cells showed GYS1 protein levels approximately 3x those of parental cells
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered minor, flagship, core and strategic.

• Carlsbad Manufacturing Facility PartnerminorOEM/ Whitelabel/ Licensing Partner · 1 November 2023GMP-compliant topical production facility launched in Carlsbad in November 2023 as part of CDMO expansion, though specific manufacturing partner not explicitly named.
• CGA Intellectual Holdings Inc. (Dr. David Aguilar)flagshipOEM/ Whitelabel/ Licensing Partner · 1 August 2023Letter of Intent signed to acquire stem cell disruptive technology and patents (ABBIE). Dr. David Aguilar, along with partners, owns CGA Intellectual Holdings which holds patents for ABBIE gene editing technology. Technology previously licensed to develop CAR-T immunotherapies.
• Stallion Laboratories Pvt. Ltd.coreChannel Partner/ Reseller/ Distributor · 26 April 2023Exclusive distribution agreement for Levetiracetam anti-epileptic medication. Stallion Laboratories, an India-based pharmaceutical company, received exclusive rights to distribute SOHM's Levetiracetam product for epilepsy treatment in their market.
• BrainwisecoreStrategic or Co-development Partner · 30 November 2021SOHM collaborated for commercial manufacturing of Brainwise patented Omega 3 formula for global distribution. This partnership leveraged SOHM's manufacturing capabilities for a proprietary pharmaceutical-grade nutritional supplement.
• Ranbaxy (now part of Sun Pharma)coreChannel Partner/ Reseller/ Distributor · 10 May 2012SOHM India Pvt. Ltd., an Indian subsidiary of SOHM Inc., entered into an agreement with Ranbaxy for dermatology product distribution. Ranbaxy, one of India's largest pharmaceutical companies, distributed SOHM's dermatology products in the Indian market.
• Coastar TherapeuticsstrategicTechnology or IntegrationCollaboration for new delivery systems to minimize immune recognition of engineered proteins in ABBIE-based CAR-T therapies. Strategic partnership for next-generation cellular immunotherapy development.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Amphastar Pharmaceuticals: US generic injectables and inhalation pharmaceutical manufacturer with integrated R&D and manufacturing. Comparable generic-pharma manufacturer with vertical integration similar to SOHM's model.
• Lannett Company: Small-cap US generic pharmaceutical manufacturer focused on off-patent molecules with diversified product portfolio. Most directly comparable to SOHM in scale, generic-pharma focus, and public-micro-cap profile.
• ANI Pharmaceuticals: US specialty generics and CDMO player combining in-house manufacturing with contract services. Comparable to SOHM's hybrid generic-pharma + CDMO service model.
• Padagis: Topical and specialty generics manufacturer spun out of Perrigo, focused on off-patent prescription and OTC products. Closely comparable to SOHM's topical generics and OTC portfolio.

Broad incumbents

• Patheon (Thermo Fisher Scientific): Large-scale CDMO services platform within Thermo Fisher offering drug substance, drug product, and biologics manufacturing. Comparable to SOHM's CDMO unit but at global-enterprise scale.
• Catalent: Global CDMO leader offering formulation, manufacturing, and packaging services across dosage forms. Comparable to SOHM's CDMO services unit but at vastly larger scale and broader capability.
• Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with broad portfolio including Levetiracetam. Represents the large-scale competitive force in SOHM's core generic and emerging-market segments.
• Lupin Pharmaceuticals: India-headquartered global generic and specialty pharma company with significant US generics business. Comparable generic-pharma competitor with established manufacturing and emerging-market distribution.

Emerging players

• Beam Therapeutics: Clinical-stage base-editing gene editing company developing precision genetic medicines. Comparable technology adjacency to SOHM's ABBIE non-viral gene editing platform.
• Intellia Therapeutics: Clinical-stage gene editing company developing CRISPR/Cas9-based in vivo and ex vivo therapies. Comparable to SOHM's ABBIE platform ambition but at advanced clinical stage with major partner backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/sohminc
• YouTubeyoutube.com/@sohminc
• Facebookfacebook.com/sohm-inc-usa-109287399176948
• LinkedInlinkedin.com/company/sohm-inc.
• Instagraminstagram.com/sohminc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SOHM